Propelx has participated in the pre-seed funding round for NeuroAge Therapeutics, advancing their AI brain health platform, led by Gates Ventures in partnership with the Alzheimer’s Drug Discovery Foundation and R42 Group. This investment marks another step forward in our mission to support early-stage companies that are redefining health outcomes through cutting-edge science and technology.
How NeuroAge AI Brain Health Platform is Redefining Cognitive Care
NeuroAge Therapeutics is developing an AI-powered diagnostic platform aimed at detecting and proactively managing brain aging. Their flagship NeuroAge Test integrates multiple data sources, including brain MRI, cognitive testing, proprietary blood biomarkers, and genetic information, into a single actionable measure of brain age. This comprehensive approach enables clinicians and patients to identify early signs of cognitive decline and take preventive measures before irreversible damage occurs.
By shifting the focus from late-stage treatment to early detection and prevention, NeuroAge is redefining how the world approaches cognitive health. With this latest funding milestone, the company will accelerate the development of its AI platform, expand clinical validation, and strengthen collaborations across the longevity and preventive health ecosystem.
Founded by Dr. Christin Glorioso, MD, PhD, an MIT-trained physician-neuroscientist, NeuroAge brings together expertise in neuroscience, artificial intelligence, and preventive medicine. The team draws experience from world-class institutions, including Massachusetts Institute of Technology, Pfizer, University of California, Berkeley, University of Cambridge, and One Medical, ensuring a robust and research-driven approach to tackling brain health challenges.
At Propelx, we are proud to support NeuroAge Therapeutics as they scale responsibly and work toward transforming brain health for millions worldwide. By investing early, we continue to empower innovators who are building technologies that not only extend life but also improve the quality of life.
